Chlorzoxazone

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70954-085
  • Package NDC 70954-085-10
  • Package NDC 70954-085-20
  • Application number ANDA212254
  • SPL ID 9dce6a48-2f53-4a21-8b9a-736afee9c5f1
  • SPL set ID 69c87a85-4b6b-405b-9fa5-4c91c0f90c70
  • UNII H0DE420U8G
  • RxCUI 197502

What the source publishes

Labeler
Novitium Pharma LLC
Active ingredients
Chlorzoxazone
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70954-085_9dce6a48-2f53-4a21-8b9a-736afee9c5f1
{
  "name": "Chlorzoxazone",
  "splId": "9dce6a48-2f53-4a21-8b9a-736afee9c5f1",
  "labels": [
    {
      "setId": "69c87a85-4b6b-405b-9fa5-4c91c0f90c70",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69c87a85-4b6b-405b-9fa5-4c91c0f90c70",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=69c87a85-4b6b-405b-9fa5-4c91c0f90c70"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Novitium Pharma LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (70954-085-10)",
      "package_ndc": "70954-085-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190912"
    },
    {
      "sample": false,
      "description": "500 TABLET in 1 BOTTLE (70954-085-20)",
      "package_ndc": "70954-085-20",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190912"
    }
  ],
  "productId": "70954-085_9dce6a48-2f53-4a21-8b9a-736afee9c5f1",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "70954-085",
  "deaSchedule": null,
  "genericName": "Chlorzoxazone",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CHLORZOXAZONE",
      "strength": "500 mg/1"
    }
  ],
  "applicationNumber": "ANDA212254",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190912",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175730",
      "N0000175737"
    ],
    "upc": [
      "0370954085201",
      "0370954085102"
    ],
    "unii": [
      "H0DE420U8G"
    ],
    "rxcui": [
      "197502"
    ],
    "spl_set_id": [
      "69c87a85-4b6b-405b-9fa5-4c91c0f90c70"
    ],
    "pharm_class_pe": [
      "Centrally-mediated Muscle Relaxation [PE]"
    ],
    "pharm_class_epc": [
      "Muscle Relaxant [EPC]"
    ],
    "manufacturer_name": [
      "Novitium Pharma LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70954-085_9dce6a48-2f53-4a21-8b9a-736afee9c5f1"